General Information of the Compound
Compound ID
CP0941679
Compound Name
4-(1H-imidazol-1-yl)-1-[2-(piperidin-1-yl)ethyl]-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C15H19N7
Molecular Weight
297.366
Canonical SMILES
c1cn(-c2ncnc3c2cnn3CCN2CCCCC2)cn1
    Show/Hide
InChI
InChI=1S/C15H19N7/c1-2-5-20(6-3-1)8-9-22-15-13(10-19-22)14(17-11-18-15)21-7-4-16-12-21/h4,7,10-12H,1-3,5-6,8-9H2
    Show/Hide
InChIKey
JBHAFGOUUNCIMT-UHFFFAOYSA-N
Physicochemical Property
logP
1.4979
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
64.66
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71226084
ChEMBL ID
CHEMBL4284731
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 13803 nM
   TI
   LI
   LO
   TS